These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3223004)

  • 1. [Reduced suppression of gastric acid by ranitidine in severe reflux esophagitis. A pilot study].
    Koop H; Klein M; Bauer A; Arnold R
    Z Gastroenterol; 1988 Jul; 26(7):345-50. PubMed ID: 3223004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.
    Fiorucci S; Santucci L; Morelli A
    Am J Gastroenterol; 1990 Nov; 85(11):1458-62. PubMed ID: 2239873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
    Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
    Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis.
    Cucchiara S; Minella R; Iervolino C; Franco MT; Campanozzi A; Franceschi M; D'Armiento F; Auricchio S
    Arch Dis Child; 1993 Dec; 69(6):655-9. PubMed ID: 8285777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of reflux oesophagitis of moderate and severe grade with ranitidine or pantoprazole--comparison of 24-hour intragastric and oesophageal pH.
    Armbrecht U; Abucar A; Hameeteman W; Schneider A; Stockbrügger RW
    Aliment Pharmacol Ther; 1997 Oct; 11(5):959-65. PubMed ID: 9354207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP; Schenk E; Tan G; Snel P; Nelis F
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug therapy of gastroesophageal reflux (a prospective controlled clinical trial)].
    Wittmann T; Rosztóczy A; Fehér A; Jármay K; Oláh T; Szendrényi V; Kiss I
    Orv Hetil; 1998 May; 139(18):1077-81. PubMed ID: 9608770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours.
    Netzer P; Gaia C; Sandoz M; Huluk T; Gut A; Halter F; Hüsler J; Inauen W
    Am J Gastroenterol; 1999 Feb; 94(2):351-7. PubMed ID: 10022628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dose famotidine in ranitidine resistant severe oesophagitis: a pilot study.
    Edge DP
    N Z Med J; 1990 Apr; 103(887):150-2. PubMed ID: 2342670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic factors influencing healing of reflux esophagitis. A controlled trial of omeprazole versus ranitidine. Study group Omega].
    Barbier JP; Haccoun P; Bergmann JF; Arnould B; Hamelin B
    Ann Gastroenterol Hepatol (Paris); 1993; 29(4):213-8. PubMed ID: 8239492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of relapse of reflux oesophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.
    Lundell L
    Digestion; 1990; 47 Suppl 1():72-5. PubMed ID: 2093020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
    Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
    Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Omeprazole (20 mg daily) compared to ranitidine (150 mg twice daily) in the treatment of esophagitis caused by reflux. Results of a double-blind randomized multicenter trial in France and Belgium].
    Zeitoun P; Rampal P; Barbier P; Isal JP; Eriksson S; Carlsson R
    Gastroenterol Clin Biol; 1989 May; 13(5):457-62. PubMed ID: 2666237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 24-hour intragastric acidity and plasma gastrin during long-term treatment with omeprazole or ranitidine in patients with reflux esophagitis.
    Lind T; Cederberg C; Idström JP; Lönroth H; Olbe L; Lundell L
    Scand J Gastroenterol; 1991 Jun; 26(6):620-6. PubMed ID: 1862300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High doses of ranitidine in patients with reflux oesophagitis.
    Jansen JB; Lamers CB
    Scand J Gastroenterol Suppl; 1990; 178():42-6. PubMed ID: 2277968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of oxmetidine and ranitidine on reflux behavior in patients with esophagitis].
    Weiser HF; Gubernatis G; Siewert JR
    Z Gastroenterol; 1983 Oct; 21(10):580-4. PubMed ID: 6139923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [2 or 1 daily doses of ranitidine in the treatment of reflux esophagitis].
    Rohner HG; Wienbeck M
    Z Gastroenterol; 1986 Aug; 24(8):396-402. PubMed ID: 3532593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.
    Baldi F; Morselli-Labate AM; Cappiello R; Ghersi S;
    Am J Gastroenterol; 2002 Jun; 97(6):1357-64. PubMed ID: 12094850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.